Background: Epidemiological studies suggest that serum calcium levels correlate with cardiovascular events. An ankle-brachial index (ABI) between 0.9 and 1.00 is a surrogate estimation of preclinical peripheral arterial disease (PAD). Prior studies have shown that an ABI of 0.9-1.0 is also associated with endothelial dysfunction. Therefore, we sought to investigate the relationship between serum calcium levels and preclinical PAD in apparently healthy Korean individuals. Methods: We evaluated the association between serum calcium levels and preclinical PAD in 596 participants (334 males, 262 females) in a health examination program. Preclinical PAD was defined by an ABI of 0.9-1.0. Multiple logistic regression analysis was used to determine whether the serum calcium level was an independent determinant of preclinical PAD. Results: The overall prevalence of preclinical PAD was 14.3%. The mean age was 44.0±12.5 years in the non-PAD group and 48.3±11.4 years in the preclinical PAD group (P=0.001). After adjusting for age, gender, systolic blood pressure, fasting plasma glucose, high-density lipoprotein cholesterol, triglycerides, C-reactive protein, g-glutamyltransferase, uric acid, hypertension medication, diabetes medication, and hyperlipidemia medication, the odds ratio (95% confidence intervals) for preclinical PAD was 2.28 (1.02-5.11) with a 1-mg/dL increase in the serum calcium. Conclusion: These findings suggest that increased serum calcium is independently and positively associated with preclinical PAD regardless of the presence of classic cardiovascular risk factors.
INTRODUCTION
Calcium is a pervasive divalent cation that is involved in blood coagulation, skeletal mineralization, muscle withdrawal, and nerve sensitivity. It is finely managed by the balance of calcitonin and parathyroid hormone (PTH). 1, 2) Epidemiological data over time suggest that serum calcium levels are associated with cardiovascular events. 1) Calcium supplementation is thought to be beneficial for bone health in children, young adults, the elderly, and menopausal females. However, there is also a concern regarding the possible relationship between serum calcium and incident cardiovascular illness. 1) Elevated serum calcium may have an early effect on cardiovascular morbidity through its effects on arterial stiffness. 3) Several mechanisms may explain calcium's effects on cardiovascular morbidity. An increased serum calcium level affects pyrophosphate, which is an important inhibitor of tissue calcification, by binding to the calcium-sensing receptor and altering endothelial function. In addition, elevated serum calcium levels can influence blood coagulation, thereby increasing the rates of cardiovascular events and mortality.
3)
The ankle-brachial index (ABI) is a simple, noninvasive clinical test that is not only useful in the diagnosis of peripheral arterial disease (PAD) but also in yielding important prognostic information about future cardiovascular events. [4] [5] [6] [7] [8] [9] Measuring the ABI involves recording the systolic pressures in the brachial artery at each elbow, in the posterior tibial artery, and in the dorsalis pedis arteries at each ankle. 4, 9, 10) The ratio of the ankle systolic pressure to the higher brachial pressure can then be ascertained. 4, [10] [11] [12] The ABI is calculated for each leg separately, and the lower of the two values is considered the result. 9, 12) PAD is diagnosed by an ABI of ≤0.9 and graded as mild to moderate if the ABI is between 0.4 and 0.9 and severe if <0.40. [5] [6] [7] 10) An ABI value >1.4 is also considered abnormal and suggestive of non-compressible vessels. [5] [6] [7] 10) Previous studies have found ABIs of 0.9-1.00 to be associated with endothelial dysfunction.
5) The association between serum calcium level and borderline ABI (as a surrogate marker of preclinical PAD) is poorly understood. Therefore, we sought to investigate the relationship between serum calcium level and preclinical PAD, as defined by an ABI of 0.9-1.0, in apparently healthy Korean individuals.
METHODS

Study Population
We 
Data Collection
The medical staff performed every examination according to the same procedures. Participants were asked about their lifestyle (including cigarette smoking, alcohol consumption), physical activity (more or less than two times per week), and whether or not they were currently being treated for any disease. If the patients were currently being treated for a specific condition, they were asked for the date of diagnosis determined by a P-value <0.05. Table 1 shows the general characteristics of the study population (n=596). The overall prevalence of preclinical PAD was 14.3%. The mean age was 44.0±12.5 years in the non-PAD group and 48.3±11.4
RESULTS
years in the preclinical PAD group (P=0.001). The mean BMI (kg/m 2 ) was 23.8±2.9 in the control group and 23.5±2.9 in the preclinical PAD group (P=0.404). Fasting plasma glucose and C-reactive protein levels were higher in the preclinical PAD group than in the control group, although these differences were not statistically significant. Figure 1 shows the unadjusted spline curve between serum calcium levels and preclinical PAD. The probability of preclinical PAD gradually increased according to serum calcium. Figure 2 shows the spline curve between serum calcium levels and preclinical peripheral arterial disease after adjusting for the same variables on Table 2 , and the results
showed that the logarithm of odds ratio for ABI lower than 1.0 tends to be increasing according to serum calcium level. 
DISCUSSION
In this population based, cross-sectional study, there was a positive association between higher serum calcium levels and preclinical PAD (independent of classic cardiovascular risk factors). Preclinical PAD It is also the main site of atherosclerosis and its clinical ramifications, including myocardial infarction and stroke. 13) In the presence of cardiovascular risk factors, including hypercholesterolemia, hypertension, diabetes, and smoking, the endothelium has decreased nitro oxide accessibility. Ultimately, this change damages the endothelium and its ability to vasodilate. 5, 13) Such endothelial dysfunction increases the risk of major cardiovascular morbidity. 13) To prevent cardiovascular events, it is clinically imperative that the treatment of atherosclerosis be properly researched before progression to advanced atherosclerosis with gravely injured vessels. 10, 14) Certain mechanisms may explain the significant relationship between serum calcium levels and cardiovascular diseases.
3) Accumulating evidence demonstrates that higher serum calcium levels are associated with increased risk of cardiovascular events. For example, there is increased carotid artery plaque thickness and abdominal aortic calcification in individuals with elevated calcium levels, suggesting that calcium directly affects the vessel walls. 3) Arterial stiffness is also known to be associated with cardiovascular disease. 15) Another possible mechanism is through the binding of calcium with pyrophosphate, which is an important inhibitor of tissue calcification. In the context of excess serum calcium, there is reduced pyrophosphate, and subsequently there may be more tissue calcification. Additional prospective studies in a large patient population are needed to substantiate these findings. Lastly, in the present study, as the serum calcium increases the probability of ABI lower than 1.0 tended to be stabilized in the adjusted spline curve. Relatively small numbers of participants with serum calcium level >9.5 mg/dL were included in the study population.
In conclusion, our findings demonstrate that increased serum calcium levels are independently and positively associated with preclinical PAD irrespective of classical cardiovascular risk factors in apparently healthy Korean adults. 
